1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid, 95%, 25g

2-Amino-5-bromobenzamide, 97.0%, 25g

2-(Bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol hydrochloride, 95.0%, 10g

2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-, hydrochloride (1:2), 50mg

4-(Bromoacetyl)pyridine hydrobromide, 5g

(R)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, 97%, 100mg

L-Isoleucine, min 98,5 %, USP, pour la biochimie, 100 g, emballage plastique.

5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid 1-(9H-fluoren-9-ylmethyl) ester, 98%, 1g

Diethyl 2-methylenesuccinate (stabilised with TBC), 95.0%, 500g

2-(2,4-DINITROPHENOXY)ETHANOL, 97.0%, 1g

3-[3-(2-Carboxyeth-1-en-1-yl)phenyl]prop-2-enoic acid, 95, 50mg

Cinnoline, 95.0%, 100mg

2-Phenoxyacetyl chloride, 98.0%, 5g